Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 161
Infectious Diseases Drugs 123
Genomics 100
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 52
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 37
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 12
Healthcare Services 10
Diagnostics 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Lung Cancer Drugs 6
Hepatology 5
Women's Health 5
Colon Cancer Drugs 5
Analgesics 5
Nanomedicine 5
Company Reports 4
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

1,018 Results (Page 30 of 51)
- Relevance
  Sort by

Prescription Drugs - Global Strategic Business Report

 Report
October 2026
362 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

Condyloma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1838EUR$2,000USD£1,563GBP

Specialty Pharmaceuticals - Global Strategic Business Report

 Report
October 2026
291 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

Autoimmune Drugs - Global Strategic Business Report

 Report
October 2026
287 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

Anti-Inflammatory Drugs - Global Strategic Business Report

 Report
October 2026
488 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Chronic Lymphocytic Leukemia Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Breast Cancer Therapeutics Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography

 Report
October 2023
204 Pages
Global

From

€4091EUR$4,450USD£3,478GBP

Atopic Dermatitis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Atrial Fibrillation Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
91 Pages
Global

From

€3500EUR$4,079USD£3,080GBP

Cystitis- Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1379EUR$1,500USD£1,172GBP

Oncologists Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Coronary Artery Disease Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Sterile Injectable Drugs - Global Strategic Business Report

 Report
October 2026
345 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

Cystic Fibrosis Therapeutics Market Report by Drugs Type, Route of Administration, Distribution Channel, Countries and Company Analysis 2026-2034

 Report
April 2026
200 Pages
Global

From

€2749EUR$2,990USD£2,337GBP

Cystic Fibrosis Therapeutics Market Report by Drug Class, Drug Molecule Type, Route of Administration, End-User, and Region 2026-2034

 Report
May 2026
139 Pages
Global

From

€3676EUR$3,999USD£3,125GBP

Liposomal Drug Delivery Devices Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Antimicrobial Therapeutics Market 2024-2028

 Report
June 2024
175 Pages
Global

From

€2298EUR$2,500USD£1,954GBP

Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

 Report
March 2025
211 Pages
Global

From

€4274EUR$4,650USD£3,634GBP

Catecholamines - Global Strategic Business Report

 Report
October 2026
372 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

Neuralgia Treatment - Global Strategic Business Report

 Report
October 2026
276 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

1,018 Results (Page 30 of 51)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.